Concepedia

S Mestiri

SM

Statistics

Publications

7

Citations

258

H-Index

7

Active since

2007

Affiliations

Hamad Medical Corporation(Current)

National Center for Cancer Care and Research

Hamad bin Khalifa University

Qatar University

S Mestiri is an author at Hamad Medical Corporation specializing in oncology, cancer immunology, and immunology.

Publications per year

2007–2024

7

Publications

7

Chronic inflammation and cancer; the two sides of a coin

Queenie Fernandes, Varghese Inchakalody, Takwa Bedhiafi et al. · Life Sciences · 2023 · 117 citations

Life Sciences, Immunology, Oncology +12

DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas

Myriam Ben Dhiab, Sonia Ziadi, S Mestiri et al. · Cellular Oncology · 2015 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report

Maysaloun Merhi, Afsheen Raza, Varghese Inchakalody et al. · Journal for ImmunoTherapy of Cancer · 2020 · 29 citations · Full text

Medicine, Immunology, Oncology +17

The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling

Emmanuel Laplantine, Christine Chable-Bessia, Anne Oudin et al. · iScience · 2022 · 25 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy

Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody et al. · Journal of Translational Medicine · 2023 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7